Cargando…

Immunoengineered adjuvants for universal vaccines against respiratory viruses

Detalles Bibliográficos
Autores principales:	Wang, Ji, Xie, Xi, Jiang, Shibo, Lu, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Publishing Services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2021
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7826133/ http://dx.doi.org/10.1016/j.fmre.2021.01.010

Ejemplares similares

Gene delivery for immunoengineering
por: Neshat, Sarah Y, et al.
Publicado: (2020)

Oral drug delivery for immunoengineering
por: Le, Tien, et al.
Publicado: (2021)

T cell immunoengineering with advanced biomaterials
por: Delcassian, Derfogail, et al.
Publicado: (2017)

Freeze-drying for the preservation of immunoengineering products
por: Kommineni, Nagavendra, et al.
Publicado: (2022)

A Perspective on the Roles of Adjuvants in Developing Highly Potent COVID-19 Vaccines
por: Zhang, Naru, et al.
Publicado: (2022)

Nanoparticle-Based Immunoengineered Approaches for Combating HIV
por: Bowen, Allan, et al.
Publicado: (2020)

The sixth revolution in pediatric vaccinology: immunoengineering and delivery systems
por: Soni, Dheeraj, et al.
Publicado: (2020)

Nanotechnology-enabled immunoengineering approaches to advance therapeutic applications
por: Chuang, Skylar T., et al.
Publicado: (2022)

Scaffold-Mediated Immunoengineering as Innovative Strategy for Tendon Regeneration
por: Russo, Valentina, et al.
Publicado: (2022)

Biomaterial-based immunoengineering to fight COVID-19 and infectious diseases
por: Zarubova, Jana, et al.
Publicado: (2021)

Prospects for Universal Influenza Virus Vaccine
por: Gerhard, Walter, et al.
Publicado: (2006)

Immunoengineered MXene nanosystem for mitigation of alloantigen presentation and prevention of transplant vasculopathy
por: Yan, Weiang, et al.
Publicado: (2023)

Sperm protein 17 targeting for epithelialovarian cancer treatment in the eraof modern immunoengineering
por: Poplawska, Maria, et al.
Publicado: (2021)

Immunoengineering via Chimeric Antigen Receptor-T Cell Therapy: Reprogramming Nanodrug Delivery
por: Katopodi, Theodora, et al.
Publicado: (2023)

ROS Cocktails as an Adjuvant for Personalized Antitumor Vaccination?
por: Clemen, Ramona, et al.
Publicado: (2021)

New Approaches to Vaccine Adjuvants: Inhibiting the Inhibitor
por: Graham, Barney S
Publicado: (2006)

Immunoengineered magnetic-quantum dot nanobead system for the isolation and detection of circulating tumor cells
por: Zhang, Pengfei, et al.
Publicado: (2021)

Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus
por: Zhang, Naru, et al.
Publicado: (2016)

Learning from the past: development of safe and effective COVID-19 vaccines
por: Su, Shan, et al.
Publicado: (2020)

Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses
por: Morens, David M., et al.
Publicado: (2023)

Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
por: Geisbert, Thomas W., et al.
Publicado: (2002)

Origin, virological features, immune evasion and intervention of SARS-CoV-2 Omicron sublineages
por: Xia, Shuai, et al.
Publicado: (2022)

Disease modeling and stem cell immunoengineering in regenerative medicine using CRISPR/Cas9 systems
por: Antao, Ainsley Mike, et al.
Publicado: (2020)

Novel Vaccine Adjuvants as Key Tools for Improving Pandemic Preparedness
por: Pogostin, Brett H., et al.
Publicado: (2021)

Innate Immune Response in Respiratory System: A Double-edged Sword Against Virus Infection
por: Li, Ang, et al.
Publicado: (2021)

Universal Vaccines: Shifting to One for Many
por: Cassone, Antonio, et al.
Publicado: (2010)

Challenges in Maximizing Impacts of Preventive Strategies against Respiratory Syncytial Virus (RSV) Disease in Young Children
por: Zheng, Zhe
Publicado: (2022)

Inhalation of vaccines and antiviral drugs to fight respiratory virus infections: reasons to prioritize the pulmonary route of administration
por: Heida, Rick, et al.
Publicado: (2023)

Health Benefits of Universal Influenza Vaccination Strategy
por: Viboud, Cécile, et al.
Publicado: (2008)

The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions?
por: Bretscher, Peter A.
Publicado: (2023)

Viral Interference between Respiratory Viruses
por: Piret, Jocelyne, et al.
Publicado: (2022)

Universal vaccine against respiratory syncytial virus A and B subtypes
por: Lee, Jeong-Yoon, et al.
Publicado: (2017)

Adenovirus-based vaccines against avian-origin H5N1 influenza viruses
por: He, Biao, et al.
Publicado: (2015)

Effect of Different Adjuvants on Immune Responses Elicited by Protein-Based Subunit Vaccines against SARS-CoV-2 and Its Delta Variant
por: Zhang, Naru, et al.
Publicado: (2022)

Porcine Reproductive and Respiratory Syndrome Virus: Origin Hypothesis
por: Plagemann, Peter G.W.
Publicado: (2003)

Respiratory Syncytial Virus Entry Inhibitors Targeting the F Protein
por: Sun, Zhiwu, et al.
Publicado: (2013)

Global respiratory virus surveillance: strengths, gaps, and way forward
por: Gupta, Swati, et al.
Publicado: (2022)

Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections
por: Stubbs, Brianna J., et al.
Publicado: (2020)

Making Better Influenza Virus Vaccines?
por: Palese, Peter
Publicado: (2006)

Research and development of Zika virus vaccines
por: Dawes, Brian E, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8dlqh69igksn4ttfk8mb1fejpf